Shows in Biological Technology

Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose

QUEBEC CITY, July 30 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has achieved additional positive ...

Video shows nanotube spins as it grows

HOUSTON -- (July 27, 2009) -- New video showing the atom-by-atom growth of carbon nanotubes reveals they rotate as they grow, much like the halting motion of a mechanical clock's second hand. Published online this month by researchers at France's Universit Lyon1/CNRS and Houston's Rice University,...

MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients

DALLAS, July 23 /PRNewswire-FirstCall/ -- AC C E S S PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) , announced today that its European partner, SpePharm , is collecting data from a post approval study of MuGard in head and neck cancer patients undergoing...

Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients

CHICAGO, July 22 /PRNewswire-FirstCall/ -- Research presented at the American Association for Clinical Chemistry (AACC) annual meeting today indicates that monitoring cardiac transplant patients with the Urine NGAL assay on Abbott's ARCHITECT immunoassay analyzer may help clinicians to m...

Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost

A two-tiered scanning-protocol for inspecting all containers at international ports could be the most affordable approach to ensuring containers moving through the global transportation system are not carrying nuclear bombs, according to a paper being presented at a services special interest group...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

CHICAGO, June 23 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced that a second non-human primate study involving its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day course of Restanza achieved a 100% su...

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

COPENHAGEN, June 4 /PRNewswire/ -- Santaris Pharma today announced that the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed early signs of clinical benefit in previously treated cancer patient...

Biotech Shows Glimmer of an Upward Trend

SAN FRANCISCO, June 1 /PRNewswire/ -- The markets closed out May in positive territory following on from their April performance...which was their best month in nine years. The Dow Jones industrial average posted its third straight monthly gain closing up 4 percent with the Nasdaq close behind - u...

SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System

VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX ) has reported positive outcomes from a substudy of patients with left main coronary disease who were treate...

deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease

Reykjavik, ICELAND, May 17 /PRNewswire-FirstCall/ -- In a paper published today in the online edition of Nature Genetics, scientists from deCODE genetics (Nasdaq: DCGN ) and academic colleagues from Iceland, Denmark and the Netherlands present the discovery of single letter variations in the ...

Brain research shows past experience is invaluable for complex decision making

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that past experience really does help when we have to make complex decisions based on uncertain or confusing information. They show that learning from experience actually changes the circuitry in ou...

New Danish research shows how oil gets stuck underground

Now, new Danish research may have come up with an explanation as to where and how North Sea oil clings to underground rocks. This explanation could turn out to be the first step on the way to developing improved oil production techniques with the intent of increasing oil production from Danish oil...

CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies

Peptide-based vaccines could prove efficacious for both prophylactic and therapeutic treatments VIENNA, Va., April 28 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) announced today that preclinical studies have demonstrated that vaccines utilizing its proprietary L.E.A.P.S....

New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU

First Study to Expand PVI Utility Beyond the OR Presented at the 29th International Symposium on Intensive Care and Emergency Medicine in Brussels IRVINE, Calif., March 31 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motio...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

Large Cardiovascular Outcomes Study To Be Initiated Manufacturing Comparability Analysis Complete: Exenatide Once Weekly NDA Submission Remains On Track SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), El...

Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene

A recent study using state-of-the-art genetic testing shows that an all natural skin care product called Ambra-Lift™ by Elina™ Organics activates Sirtuin-1, a key anti-aging gene. Until now only Resveratrol, a substance found in the skin of grapes and red wine, has been known to ...

Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond

More than 80% of Nearly 4,000 Participants Attend InformexUSA 2009 to Gather Information about Advances in the Chemical Industry PRINCETON, N.J., March 24 /PRNewswire/ -- In a survey conducted at the leading chemical exhibition in the United States -- InformexUSA -- visitors affiliated with t...

White Paper Shows How to LEED the Way With Green Design

NEEDHAM, Mass., March 24 /PRNewswire/ -- Industry sources estimate that U.S. healthcare facilities spend approximately $5.3 billion annually for energy costs alone. Hospital administrators planning ahead for a new facility would face considerable escalation of such costs for the foreseeable future...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

TUSTIN, Calif., November 23, 2008 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug ba...

Genencor Shows How Industrial Biotech Breakthroughs Contribute to the New Green Economy

Event showcases sustainable solutions for biofuels, biochemicals and textile processing PALO ALTO, Calif., March 20 /PRNewswire-USNewswire/ -- Yesterday, Genencor, a division of Danisco A/S, hosted a private tour of its Bay Area Research and Development headquarters to a group of industr...

Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice

San Diego-Based Carolus Therapeutics Focuses on Discovery and Development of Anti-Inflammatory Drugs Based on Collaborators' Findings at RWTH Aachen University in Germany SAN DIEGO, Jan. 5 /PRNewswire/ -- Research published in Nature Medicine shows that the disruption of the interactions be...

Study Shows Machine Perfusion Significantly Improves Transplant Results

CHICAGO, Dec. 31 /PRNewswire/ -- A landmark study published today in the New England Journal of Medicine (NEJM) demonstrates that use of a specially-designed machine to store kidneys for transplantation offers significant benefits in kidney survival and function when compared to those stored in a ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

TUSTIN, Calif., November 23, 2008 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug ba...

NPL research shows there could be no end in sight for Moore’s Law

The fast pace of growing computing power could be sustained for many years to come thanks to new research from the UK's National Physical Laboratory (NPL) that is applying advanced techniques to magnetic semiconductors. Moore's Law observed that the density of transistors on an integrated circ...

Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA

CHICAGO, Dec. 5 /PRNewswire/ -- Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-...

OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

First-line trial currently shows median overall survival of 27.5 months for OGX-011 in combination with docetaxel and prednisone and a 16.9 months overall survival for docetaxel and prednisone alone. Achievement of survival benefit milestone results in release of ...

NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen

New Analysis of the 104 ABPM Study Presented at the American Heart Association http://www.nicox.com SOPHIA ANTIPOLIS, France, November 12 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced that a new analysis of...

Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial

AMD Patients Treated with POT-4 Demonstrate No Adverse Toxic Effects ATLANTA, Nov. 10 /PRNewswire/ -- Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), presented Phase I data last week during the...

Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure

SAN MATEO‚ Calif.‚ Nov. 10 /PRNewswire/ -- Corthera Inc. today announced that an interim analysis of top-line data from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, international study, showed favorable efficacy and safety for relaxin, the compan...

New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD

- More than one quarter (26%) of primary care patients 40 years of age and older with a smoking history and symptoms of chronic bronchitis had airflow obstruction consistent with a diagnosis of COPD - Percentages were greater with increasing patient age and smoking history PHILADELP...

Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies

- Both 12-month pivotal studies in patients with symptomatic Chronic Obstructive Pulmonary Disease (COPD) meet primary endpoints - Data show reductions in moderate and severe exacerbations requiring medical intervention - Application for marketing authorisation in EU and US expected in 200...

Jellyfish Protein Shows Potential to Help With Memory

BOSTON, Oct. 15 /PRNewswire/ -- Quincy Bioscience (Madison, WI) announces that Prevagen(R) (http://www.prevagen.com ), a dietary supplement consisting of the jellyfish protein apoaequorin, has displayed great potential to improve memory in healthy human subjects tested. The Prevagen Memory St...

Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents

Supports use of AHCC for immune enhancement during cold & flu season PURCHASE, N.Y., Sept. 24 /PRNewswire/ -- A new paper published in Nutrition Reviews (Vol. 66(9):526-531) by Dr. Barry W. Ritz, PhD, Department of Bioscience and Biotechnology at Drexel University, has shown how AHCC impacts...

New carbon material shows promise of storing large quantities of renewable electrical energy

Engineers and scientists at The University of Texas at Austin have achieved a breakthrough in the use of a one-atom thick structure called "graphene" as a new carbon-based material for storing electrical charge in ultracapacitor devices, perhaps paving the way for the massive installation of renew...

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

Study of More Than 60,000 Women Underscores Need for Better Understanding of Implications and Risks Associated with Osteoporosis MONTREAL, Sept. 15 /PRNewswire/ -- Results from the Global Longitudinal study of Osteoporosis in Women (GLOW) showed that 55 percent of women diagnosed with o...

Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School

Parents of students with known allergies are urged to put auto-injectable epinephrine at the top of the school supplies list SILVER SPRING, Md., Aug. 27 /PRNewswire/ -- A new survey conducted by the National Association of School Nurses (NASN) found that 72% of school nurses have stud...

PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet

- One of the First Therapies to Address the Underlying Cause of Cystic Fibrosis; Oral Drug May Represent New Treatment Paradigm - SOUTH PLAINFIELD, N.J., Aug. 20 /PRNewswire/ -- New phase 2 data published today in The Lancet show that the investigational oral drug PTC124 demonstrates activit...

Atrium shows a strong financial performance for its first quarter

Increase of 98% in net earnings from continuing operations during the first quarter of 2008 to reach 10.5 million US dollars All amounts in US dollars QUEBEC CITY, May 6 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB), a recognized leading developer, ...

A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease

Findings will be applied to diagnostic efforts and will be integrated into the deCODEme(TM) service REYKJAVIK, Iceland, April 2, 2008 /PRNewswire-FirstCall/ -- Cigarette smoking is a major public health problem that contributes to millions of deaths around the world each ...

Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion

SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) announced positive findings from its preclinical study being conducted by researchers at Emory University, which demonstrated highly efficient uptake of DNA-based vectors within acutely ischemic myocardium (heart ...